Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial

IMPORTANCE: Agitation is a prevalent, distressing, and burdensome manifestation of Alzheimer dementia in need of an efficacious, safe, and well-tolerated treatment. OBJECTIVE: To confirm the efficacy, safety, and tolerability of brexpiprazole in patients with agitation in Alzheimer dementia. DESIGN,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Daniel, Slomkowski, Mary, Hefting, Nanco, Chen, Dalei, Larsen, Klaus Groes, Kohegyi, Eva, Hobart, Mary, Cummings, Jeffrey L., Grossberg, George T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628834/
https://www.ncbi.nlm.nih.gov/pubmed/37930669
http://dx.doi.org/10.1001/jamaneurol.2023.3810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628834/
https://www.ncbi.nlm.nih.gov/pubmed/37930669
http://dx.doi.org/10.1001/jamaneurol.2023.3810

Ejemplares similares